Earnings Call Insights: Shift4 Payments (FOUR) Q1 2026 Management View "We performed in line with our previously provided guidance" and delivered "32% year-over-year growth in gross revenues" and "49% year-over-year growth in gross revenue less network fees" despite "unforeseen events in the Middle East" (Chairman of the Board, President & CEO David Lauber). "Our full year '26 guidance remains unc...
Earnings Call Insights: Shift4 Payments (FOUR) Q1 2026 Management View "We performed in line with our previously provided guidance" and delivered "32% year-over-year growth in gross revenues" and "49% year-over-year growth in gross revenue less network fees" despite "unforeseen events in the Middle East" (Chairman of the Board, President & CEO David Lauber). "Our full year '26 guidance remains unchanged, calling for 26% to 31% gross revenue less network fee growth" and management said it is "not forecasting a dramatic recovery in the back half of the year" on same-store sales (President & CEO Lauber). "Shift4 One is in 7 countries, and we are on track to be in 15 with this product by the end of the year" and management described the addressable base as "over 70,000 SMB merchants that are prospective customers on this new product" (President & CEO Lauber). "We are rebranding SkyTab to Shift4 Dine" and CEO Lauber said the rationale is: "We have a much larger and more powerful brand in Shift4, and this is simply our Dine product" (President & CEO Lauber). "The overall integration of Global Blue is on track, and we announced several Global Blue employees to key management roles during the quarter" (President & CEO Lauber). "Gross revenue less network fees, or GRLNF, of $549 million grew 49% year-over-year" and "adjusted EBITDA of $234 million" delivered "a 43% margin" (Chief Financial Officer Christopher Cruz). Outlook "For the second quarter of 2026, we are introducing guidance" of "GRLNF of $615 million" (including "an approximate $20 million impact from travel disruption due to the Middle East conflict"), "adjusted EBITDA of $278 million" and "$10 million of adjusted free cash flow" (CFO Cruz). "For the full year, we are leaving our guidance unchanged" and CFO Cruz said this "is meant to express the wider volatility of outcomes we are seeing even with part of the year complete" (CFO Cruz). On travel disruption sensitivity, CFO Cruz said: "we are not attempting to for...
Earnings Call Insights: Ingevity (NGVT) Q1 2026 Management View "This quarter marked another strong period of execution and results for our company," said (President, CEO & Director David Li), highlighting portfolio actions: "we were pleased to complete the sale of the Ozark Materials, Road Markings product line, on April 15 to PPG in an all-cash transaction valued at approximately $65 million" an...
Earnings Call Insights: Ingevity (NGVT) Q1 2026 Management View "This quarter marked another strong period of execution and results for our company," said (President, CEO & Director David Li), highlighting portfolio actions: "we were pleased to complete the sale of the Ozark Materials, Road Markings product line, on April 15 to PPG in an all-cash transaction valued at approximately $65 million" and noting the earlier divestiture "for approximately $93 million of net proceeds," adding that "the ongoing sales process for our APT business underscores our commitment to simplifying this portfolio, sharpening our strategic focus and reducing earnings volatility." (CEO Li) tied Q1 performance to profitability and capital returns: "we achieved 4% sales growth and an industry-leading EBITDA margin approaching 36%," and said this "enabled us to repurchase approximately $52 million of shares in the quarter ahead of plan." He also said Performance Materials benefited from "price increases" and "a continued shift in consumer preference from battery electric vehicles towards hybrids," while the company is "actively investing to expand into filtration" with early traction: "we already have a presence in food and beverage, medical and pharma and consumer applications." (Senior VP & CFO Phillip Platt) framed the quarter’s financial mix and notable items: "Sales grew 4% to $258 million," and "we recorded a GAAP net income of $23.4 million, which included approximately $23 million of pretax special charges, $16 million of which related to the final litigation settlement payment to BASF." On an adjusted basis, he said "adjusted gross profit of $132 million" produced "gross margin of 51%," while "adjusted EBITDA of $92 million" led to "adjusted EBITDA margin" of "35.5%." (CFO Platt) also emphasized capital allocation and leverage: "We accelerated our share repurchases in the first quarter beyond the ratable cadence we had planned, deploying $52 million to repurchase approximately 775,00...
Bill Oxford iRhythm Holdings (IRTM) traded higher on Thursday after the Centers for Disease Control and Prevention issued a finalized local coverage determination related to cardiac monitoring devices, which include the company’s Zio ECG monitoring system. The LCD from Noridian, one of three Medicare Administrative Contractors that process Medicare fee-for-service claims, was a positive for the co...
Bill Oxford iRhythm Holdings (IRTM) traded higher on Thursday after the Centers for Disease Control and Prevention issued a finalized local coverage determination related to cardiac monitoring devices, which include the company’s Zio ECG monitoring system. The LCD from Noridian, one of three Medicare Administrative Contractors that process Medicare fee-for-service claims, was a positive for the company, argued BTIG analyst Marie Thibault in a research note. According to Thibault, there was confusion when Medicare issued proposed LCDs last fall, applying requirements for mobile cardiac telemetry for what appeared to be coverage proposals for ambulatory cardiac monitoring. The finalized LCD that is set to take effect on June 21 “has clarified language to accurately reflect the various device class capabilities and FDA indications,” the analyst wrote with a Buy recommendation and a $185 per share target on iRhythm (IRTM). “We are flagging this update and view it as a positive for IRTC because even though most investors expected the revision to clarify the confusion, having it in hand eliminates any uncertainty,” she added. The analyst expects the other two MACs, Palmetto and CGS, to follow suit, as they were also included in the open comment period. More on iRhythm Technologies iRhythm Holdings, Inc. 2026 Q1 - Results - Earnings Call Presentation iRhythm Holdings, Inc. (IRTC) Q1 2026 Earnings Call Transcript iRhythm Holdings, Inc. (IRTC) Q4 2025 Earnings Call Transcript IRhythm forecasts 2026 revenue of $875M-$885M while targeting 12%-13% adjusted EBITDA margin iRhythm Technologies GAAP EPS of -$0.43 beats by $0.28, revenue of $199.4M beats by $5.31M
filo Shake Shack ( SHAK ) is down ~29% in Thursday trading after its Q1 financial results missed on both lines and also announced a new CFO. Q1 loss per share of -$0.01 compares to earnings of $0.10 in the year-ago period. While same-store sales were up 4.6% in the quarter compared to Q1 2025, the Danny Meyer-founded fast-casual restaurant chain had an operating loss of $2.6M versus operating inco...
filo Shake Shack ( SHAK ) is down ~29% in Thursday trading after its Q1 financial results missed on both lines and also announced a new CFO. Q1 loss per share of -$0.01 compares to earnings of $0.10 in the year-ago period. While same-store sales were up 4.6% in the quarter compared to Q1 2025, the Danny Meyer-founded fast-casual restaurant chain had an operating loss of $2.6M versus operating income of $2.8M in the year-ago period. The company was hit in the quarter by a rise in operating expenses to $369.4M from ~$318.1M in the year-ago period. In the quarter, Shake Shack opened 17 company-operated stores and five licensed ones. Michelle Hook is also joining the company as CFO, effective May 11. Shake Shack ended the quarter with cash and cash equivalents of ~$313.7M compared to ~$360.1M on Dec. 31, 2025. More on Shake Shack Shake Shack Inc. 2026 Q1 - Results - Earnings Call Presentation Shake Shack: Growth Setup Has Improved (Rating Upgrade) Shake Shack: Accelerating Growth And Cash Flow Inflection Support Re-Rating Shake Shack GAAP EPS of $0.00 misses by $0.14, revenue of $366.7M misses by $5.57M Shake Shack Q1 2026 Earnings Preview
Shares of budget-conscious fitness center Planet Fitness (NYSE: PLNT) are down 32% as of 11 a.m. ET after the company reported underwhelming first-quarter earnings. During Q1, Planet Fitness grew sales and adjusted earnings per share (EPS) by 22% and 25%, respectively, sailing past Wall Street's consensus. However, the company saw net new member adds decline 36% from last year's level, prompting m...
Shares of budget-conscious fitness center Planet Fitness (NYSE: PLNT) are down 32% as of 11 a.m. ET after the company reported underwhelming first-quarter earnings. During Q1, Planet Fitness grew sales and adjusted earnings per share (EPS) by 22% and 25%, respectively, sailing past Wall Street's consensus. However, the company saw net new member adds decline 36% from last year's level, prompting management to slash its 2026 guidance. Originally projecting revenue and EPS to rise by 9% in 2026, the company now expects growth closer to 7% and 4%, respectively. Worse yet, the company decided to withdraw the three-year growth algorithm it released during its 2025 Investor Day, in which it stated that sales and adjusted EPS would grow by 10% to 15% and 15% to 20%, respectively, each year. Without this rosy guidance as a benchmark, the market assigned Planet Fitness shares a lower valuation. Furthermore, due to the slowdown in new member adds, management paused its planned Black Card price increase, as they believe raising its Classic Card's price from $10 to $15 last year may have spurred this year's slowdown. This pause leaves investors wondering exactly how much pricing power Plant Fitness may command. Image source: Getty Images. Continue reading
J Studios/DigitalVision via Getty Images Mortgage rates increased again this week, marking the second consecutive weekly gain, according to the latest Freddie Mac ( FMCC ) Primary Mortgage Survey. 30-year fixed-rate mortgages averaged 6.37% as of May 7, up from 6.30% last week but below the year-ago level of 6.76%. 15-year fixed-rate mortgages averaged 5.72%, compared to 5.64% in the week before a...
J Studios/DigitalVision via Getty Images Mortgage rates increased again this week, marking the second consecutive weekly gain, according to the latest Freddie Mac ( FMCC ) Primary Mortgage Survey. 30-year fixed-rate mortgages averaged 6.37% as of May 7, up from 6.30% last week but below the year-ago level of 6.76%. 15-year fixed-rate mortgages averaged 5.72%, compared to 5.64% in the week before and 5.89% a year ago. "Recent data points to slightly better conditions for buyers with a boost in new-home sales, median new-home prices being down to their lowest level since July 2021, and higher inventory than in recent years," said Sam Khater, Freddie Mac's chief economist. "Together, these trends could modestly ease affordability pressures through the spring homebuying season," added Khater. Here is a look at the survey results: Source: Freddie Mac More on Mortgages Mortgage demand continues to dwindle Freddie Mac to begin accepting mortgage loans assessed through VantageScore 4.0
MNTN CEO Mark Douglas joins Bloomberg Open Interest to push back on the idea that TV is dying, arguing it remains the most powerful entertainment medium on earth. He explains how streaming is opening TV advertising to new businesses, why AI video tools are lowering production costs, and why the World Cup could be a massive moment for advertisers. (Source: Bloomberg)
MNTN CEO Mark Douglas joins Bloomberg Open Interest to push back on the idea that TV is dying, arguing it remains the most powerful entertainment medium on earth. He explains how streaming is opening TV advertising to new businesses, why AI video tools are lowering production costs, and why the World Cup could be a massive moment for advertisers. (Source: Bloomberg)
Secretary of State Marco Rubio traveled to Rome in an effort to preserve a crucial relationship between Washington and the Holy See. (Image credit: Vatican Media via AP)
Secretary of State Marco Rubio traveled to Rome in an effort to preserve a crucial relationship between Washington and the Holy See. (Image credit: Vatican Media via AP)
A British court has convicted two men linked to an Hong Kong Economic and Trade Office (HKETO) of spying on activists from the city on behalf of Chinese authorities. Bill Yuen Chung-biu, the London office’s manager, and Peter Wai Chi-leung were found guilty of assisting a foreign intelligence service on Thursday, two years after their arrests thrust the role of Hong Kong’s overseas promotion offic...
A British court has convicted two men linked to an Hong Kong Economic and Trade Office (HKETO) of spying on activists from the city on behalf of Chinese authorities. Bill Yuen Chung-biu, the London office’s manager, and Peter Wai Chi-leung were found guilty of assisting a foreign intelligence service on Thursday, two years after their arrests thrust the role of Hong Kong’s overseas promotion offices into the global spotlight. Yuen, a retired Hong Kong police superintendent, was earlier accused...
Police see off gatherings of teenagers in London and Edinburgh after videos of similar stunts in US go viral Hundreds of teenagers have attempted to “speed run” Scientology buildings in different parts of the UK as part of a TikTok trend that started in Los Angeles . Scientology speed running is where people rush into churches and see how far they can get before being ushered out by staff . The Ch...
Police see off gatherings of teenagers in London and Edinburgh after videos of similar stunts in US go viral Hundreds of teenagers have attempted to “speed run” Scientology buildings in different parts of the UK as part of a TikTok trend that started in Los Angeles . Scientology speed running is where people rush into churches and see how far they can get before being ushered out by staff . The Church of Scientology said using its church spaces for viral stunts was “trespass, harassment, and disruption of religious facilities”. Continue reading...
OlenaMykhaylova ADMA Biologics ( ADMA ) declined more than 17% on Thursday after the company lowered its full-year outlook and withdrew its long-term guidance, citing “uncertainty in the competitive landscape”. The stock was trading 17.7% lower at $8.30 during midday trading. The company reported a mixed Q1 print with earnings of $0.19 per share coming in line with analysts’ consensus but revenue ...
OlenaMykhaylova ADMA Biologics ( ADMA ) declined more than 17% on Thursday after the company lowered its full-year outlook and withdrew its long-term guidance, citing “uncertainty in the competitive landscape”. The stock was trading 17.7% lower at $8.30 during midday trading. The company reported a mixed Q1 print with earnings of $0.19 per share coming in line with analysts’ consensus but revenue of $114.5M missing estimates. The New Jersey-based firm now sees FY26 revenue in the range of $530 million to $560 million (vs. consensus of $629.1M), down from $635 million earlier. It has projected adjusted net income in the range of $170 million to $200 million, down from $255 million. Adjusted EBITDA is expected to be between $265 million and $300 million compared to $360 million earlier. “This outlook reflects continued ASCENIV growth, partially offset by the expectation of sustained competitive pressure in the standard IG space over the course of 2026,” CFO P. Terence Kohler said. “These expectations reflect not only the reduced revenue expectations in the year but also an expected step-up in operating expense, primarily driven by R&D spend related to our SG-001 program, but also a step-up in SG&A as we continue to invest in our commercial operations,” he added. The biotech firm saw ASCENIV revenue grow 28% Y/Y to $97.5 million while BIVIGAM revenue declined 54% Y/Y to $15.4 million. Revenue from the sale of intermediates and other products also declined year-over-year by $3.0 million, the company said. The stock has had a disappointing run in the year so far, declining more than 54% year-to-date. More on ADMA Biologics ADMA Biologics, Inc. (ADMA) Q1 2026 Earnings Call Transcript ADMA Biologics: The Short Report Is The Noise, Not The Signal ADMA Biologics: Differentiated Plasma Approach With Asymmetric Upside Potential (Rating Upgrade) Adma projects 2026 revenue of $530M-$560M and withdraws longer-term guidance amid standard IG dislocation ADMA Biologics GAAP EPS of $...